Literature DB >> 23323600

Four new koumine metabolites in rat liver microsomes.

Lin Zhang1, Lan Du, Wen-Wen Lv, Qing-Chun Zhao, Wei Hua, Ye An, Tao Guo, Li-Jun Wu.   

Abstract

Four new metabolites M-1 [1,2,18,19-tetradehydro-4-demethyl-3,17-epoxy-7,20(2H,19H)-cyclovobasan], M-2 [1,2,4,21,18,19-hexadehydro-4-demethyl-3,17-epoxy-7,20(2H,19H)-cyclovobasan], M-3 [1,2,18,19-tetradehydro-4-demethyl-4-formaldehyde-3,17-epoxy-7,20(2H,19H)-cyclovobasan], and M-4 [1,2,4,21,18,19-hexadehydro-4-demethyl-4-oxy-3,17-epoxy-7,20(2H,19H)-cyclovobasan] were isolated from the chloroform extract of koumine incubated with phenobarbital-treated rat liver microsomes. The structures of M-1, M-2, M-3, and M-4 were elucidated by spectroscopic methods including ESI-TOF-MS, 1D, and 2D NMR experiments. The metabolic pathway of koumine was proposed. The cytotoxic activities between koumine and its metabolites were also compared in the A549 cell line.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23323600     DOI: 10.1080/10286020.2012.742511

Source DB:  PubMed          Journal:  J Asian Nat Prod Res        ISSN: 1028-6020            Impact factor:   1.569


  2 in total

1.  Streptozotocin-Induced Hyperglycemia Affects the Pharmacokinetics of Koumine and its Anti-Allodynic Action in a Rat Model of Diabetic Neuropathic Pain.

Authors:  Li-Xiang Ye; Hui-Hui Huang; Shui-Hua Zhang; Jing-Shan Lu; Da-Xuan Cao; Dan-Dan Wu; Pei-Wang Chi; Long-Hui Hong; Min-Xia Wu; Ying Xu; Chang-Xi Yu
Journal:  Front Pharmacol       Date:  2021-05-13       Impact factor: 5.810

2.  On Gelsemium and Complementary and Alternative Medicine (CAM) in Anxiety and Experimental Neurology.

Authors:  Salvatore Chirumbolo
Journal:  Neurol Ther       Date:  2014-12-19
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.